Nov 14, 2022 • 4:41 PM EST Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern
Oct 20, 2022 • 4:28 PM EDT Interpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual Meeting
Sep 1, 2022 • 5:18 PM EDT Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved